{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T20:29:22Z","timestamp":1760646562257},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,11,24]],"date-time":"2016-11-24T00:00:00Z","timestamp":1479945600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Urologe"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1007\/s00120-016-0273-4","type":"journal-article","created":{"date-parts":[[2016,11,24]],"date-time":"2016-11-24T04:04:16Z","timestamp":1479960256000},"page":"40-43","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Intravesikale Radioimmuntherapie des Carcinoma in situ der Harnblase nach BCG-Versagen"],"prefix":"10.1007","volume":"56","author":[{"given":"M. E.","family":"Autenrieth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Horn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Kurtz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Morgenstern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Bruchertseifer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Schwaiger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Blechert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Seidl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Senekowitsch-Schmidtke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. E.","family":"Gschwend","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Scheidhauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,11,24]]},"reference":[{"key":"273_CR1","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/s00120-007-1467-6","volume":"46","author":"F Dorp vom","year":"2007","unstructured":"vom Dorp F et\u00a0al (2007) Prognostic factors of urinary bladder carcinoma. Urologe A 46:1139\u20131140","journal-title":"Urologe A"},{"key":"273_CR2","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/00042307-200311000-00010","volume":"13","author":"JE Gschwend","year":"2003","unstructured":"Gschwend JE et\u00a0al (2003) Bladder substitution. Curr Opin Urol 13:477\u2013482","journal-title":"Curr Opin Urol"},{"key":"273_CR3","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00345-006-0105-z","volume":"24","author":"RE Hautmann","year":"2006","unstructured":"Hautmann RE et al (2006) Long-term results of standard procedures in urology: the ileal neobladder. World J Urol 24:305\u2013314","journal-title":"World J Urol"},{"key":"273_CR4","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1200\/JCO.2006.05.8149","volume":"24","author":"C Weiss","year":"2006","unstructured":"Weiss C et al (2006) Radiochemotherapy after transurethral resection for high-risk T1 bladder cancer: an alternative to intravesical therapy or early cystectomy? J Clin Oncol 24:2318\u20132324","journal-title":"J Clin Oncol"},{"issue":"Suppl 4","key":"273_CR5","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s00120-006-1134-3","volume":"45","author":"C Stief","year":"2006","unstructured":"Stief C et\u00a0al (2006) Standards and perspectives in diagnosis and therapy of bladder carcinoma. Urologe A 45(Suppl 4):90\u201396","journal-title":"Urologe A"},{"key":"273_CR6","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/S0022-5347(05)65157-9","volume":"167","author":"MS Soloway","year":"2002","unstructured":"Soloway MS et\u00a0al (2002) Contemporary management of stage T1 transitional cell carcinoma of the bladder. J\u00a0Urol 167:1573\u20131583","journal-title":"J Urol"},{"key":"273_CR7","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/S0022-5347(05)68208-0","volume":"162","author":"JA Smith","year":"1999","unstructured":"Smith JA et\u00a0al (1999) Bladder cancer clinical guidelines panel summary report on the management of nonmuscle invasive bladder cancer (stages Ta, T1 and TIS). J\u00a0Urol 162:1697\u20131701","journal-title":"J Urol"},{"key":"273_CR8","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0302-2838(03)00140-4","volume":"43","author":"E Kaasinen","year":"2003","unstructured":"Kaasinen E et\u00a0al (2003) lternating mitomycin C and BCG instillations versus BCG alone in treatment of carcinoma in situ of the urinary bladder: a\u00a0nordic study. Eur Urol 43:637\u2013645","journal-title":"Eur Urol"},{"issue":"Suppl 5","key":"273_CR9","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/annonc\/mdj966","volume":"17","author":"P Gontero","year":"2006","unstructured":"Gontero P, Frea B (2006) Actual experience and future development of gemcitabine in superficial bladder cancer. Ann Oncol\u00a017(Suppl 5):123\u2013128","journal-title":"Ann Oncol"},{"key":"273_CR10","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00259-005-1803-2","volume":"32","author":"O Couturier","year":"2005","unstructured":"Couturier O et al (2005) Cancer radioimmunotherapy with alpha-emitting nuclides. Eur J Nucl Med Mol Imaging 32:601\u2013614","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"273_CR11","first-page":"322","volume":"50","author":"M Cherel","year":"2006","unstructured":"Cherel M et\u00a0al (2006) Current status and perspectives in alpha radioimmunotherapy. Q J Nucl Med Mol Imaging 50:322\u2013329","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"273_CR12","first-page":"4157","volume":"62","author":"H Cheng","year":"2002","unstructured":"Cheng H et\u00a0al (2002) Overexpression of epidermal growth factor receptor in urothelium elicits urothelial hyperplasia and promotes bladder tumor growth. Cancer Res 62:4157\u20131563","journal-title":"Cancer Res"},{"issue":"Suppl","key":"273_CR13","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S1040-8428(03)00067-2","volume":"46","author":"J Bellmunt","year":"2003","unstructured":"Bellmunt J et\u00a0al (2003) Novel approaches with targeted therapies in bladder cancer. Therapy of bladder cancer by blockade of the epidermal growth factor receptor family. Crit Rev Oncol Hematol 46(Suppl):85\u2013104","journal-title":"Crit Rev Oncol Hematol"},{"key":"273_CR14","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/j.1464-410X.2005.05497.x","volume":"95","author":"R Rotterud","year":"2005","unstructured":"Rotterud R et\u00a0al (2005) Expression of the epidermal growth factor receptor family in normal and malignant urothelium. BJU Int 95:1344\u20131350","journal-title":"BJU Int"},{"key":"273_CR15","doi-asserted-by":"crossref","unstructured":"Pfost B et al (2009) Intravesical alpha\u2011radioimmunotherapy with 213\u202fBi-anti-EGFR-mAb defeats human bladder carcinoma in xenografted nude mice. J\u00a0Nucl\u00a0Med 50:1700\u20131708","DOI":"10.2967\/jnumed.109.065961"},{"issue":"10","key":"273_CR16","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1080\/15384047.2015.1071735","volume":"16","author":"J Fazel","year":"2015","unstructured":"Fazel J et al (2015) Fractionated intravesical radioimmunotherpy with 213Bi-anti-EGFR-MAb is effective without toxic side-effects in a\u00a0nude mouse model of advanced human bladder carcinoma. Cancer Biol Ther 16(10):1526\u20131534","journal-title":"Cancer Biol Ther"}],"container-title":["Der Urologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-016-0273-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00120-016-0273-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-016-0273-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T00:23:09Z","timestamp":1498350189000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00120-016-0273-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,24]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["273"],"URL":"https:\/\/doi.org\/10.1007\/s00120-016-0273-4","relation":{},"ISSN":["0340-2592","1433-0563"],"issn-type":[{"value":"0340-2592","type":"print"},{"value":"1433-0563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,24]]}}}